Inventor · disambiguated record
Erik J. Rueden
Also filed as: RUEDEN ERIK · RUEDEN ERIK J
10 granted patents·8 pending applications·191 citations·filing 2002–2024
90Inventor score
Files withANADYS PHARMACEUTICALS INC8GILEAD SCIENCES INC5WEBBER STEPHEN E3AVERETT DEVRON R1KUCERA DAVID1
Top patents by PatentIndex Score
18 records- 0197US6924271B23-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2002·Granted Aug 2, 2005·123 cites·10 claims
- 0292US11344565B2Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2015·Granted May 31, 2022·19 cites·19 claims
- 0392US7560544B23,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofANADYS PHARMACEUTICALS INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0489US8097718B23,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2009·Granted Jan 17, 2012·11 cites·31 claims
- 0585US7745415B23-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2008·Granted Jun 29, 2010·6 cites·12 claims
- 0680US7928085B2P-toluene sulfonic acid salt of 5-amino-3-(2′-O-acetyl-3′-deoxy-β-D-ribofuranosyl)-3H-thiazole[4,5-d]pyrimidine-2-one and methods for preparationANADYS PHARMACEUTICALS INC·Filed 2007·Granted Apr 19, 2011·4 cites·10 claims
- 0779US7943759B23-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2010·Granted May 17, 2011·3 cites·6 claims
- 0876US8883758B23,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2013·Granted Nov 11, 2014·2 cites·12 claims
- 0976US7321033B23-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·7 cites·11 claims
- 1076US2022354873A1Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 1166US2020197422A1Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 1261US2005182001A13-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1361US2025230162A1Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1460US2025042906A1Processes for making irak4 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1558US2008090844A13-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1655US2012121541A13,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2012·Application pending·0 cites
- 1747US8193342B2Method for preparing furanose compoundsKUCERA DAVID·Filed 2011·Granted Jun 5, 2012·0 cites·10 claims
- 1845US2008070852A13-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses ThereofAVERETT DEVRON R·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erik J. Rueden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →